Caprelsa (vandetanib)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
WARNINGS AND PRECAUTIONS
Severe Skin Reactions (previously Skin Reactions and Stevens-Johnson Syndrome)
Severe and...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts